Figure 4From: Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinomaSurvival analysis of prognostic factors of patients with FLC. Age = 23 years (n = 7, median survival of 8 ± 2 months) compared to age > 23 years (n = 8, median survival of 65 ± 19 months), p = 0.0132.Back to article page